Shah, M. A., Jhawer, M., Ilson, D. H., Lefkowitz, R. A., Robinson, E., Capanu, M., & Kelsen, D. P. (2011). Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma. American Society of Clinical Oncology.
Citação norma ChicagoShah, Manish A., Minaxi Jhawer, David H. Ilson, Robert A. Lefkowitz, Edric Robinson, Marinela Capanu, and David P. Kelsen. Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma. American Society of Clinical Oncology, 2011.
MLA citiranjeShah, Manish A., et al. Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma. American Society of Clinical Oncology, 2011.